RESUMEN
INTRODUCTION: We set out to evaluate the performance of a multitarget stool DNA (MT-sDNA) in an average-risk colonoscopy-controlled colorectal cancer (CRC) screening population. MT-sDNA stool test results were evaluated against fecal immunochemical test (FIT) results for the detection of different lesions, including molecularly defined high-risk adenomas and several other tumor characteristics. METHODS: Whole stool samples (n = 1,047) were prospectively collected and subjected to an MT-sDNA test, which tests for KRAS mutations, NDRG4 and BMP3 promoter methylation, and hemoglobin. Results for detecting CRC (n = 7), advanced precancerous lesions (advanced adenoma [AA] and advanced serrated polyps; n = 119), and non-AAs (n = 191) were compared with those of FIT alone (thresholds of 50, 75, and 100 hemoglobin/mL). AAs with high risk of progression were defined by the presence of specific DNA copy number events as measured by low-pass whole genome sequencing. RESULTS: The MT-sDNA test was more sensitive than FIT alone in detecting advanced precancerous lesions (46% (55/119) vs 27% (32/119), respectively, P < 0.001). Specificities among individuals with nonadvanced or negative findings (controls) were 89% (791/888) and 93% (828/888) for MT-sDNA and FIT testing, respectively. A positive MT-sDNA test was associated with multiple lesions (P = 0.005), larger lesions (P = 0.03), and lesions with tubulovillous architecture (P = 0.04). The sensitivity of the MT-sDNA test or FIT in detecting individuals with high-risk AAs (n = 19) from individuals with low-risk AAs (n = 52) was not significantly different. DISCUSSION: In an average-risk screening population, the MT-sDNA test has an increased sensitivity for detecting advanced precancerous lesions compared with FIT alone. AAs with a high risk of progression were not detected with significantly higher sensitivity by MT-sDNA or FIT.
Asunto(s)
Adenoma/diagnóstico , Pólipos del Colon/diagnóstico , Neoplasias Colorrectales/diagnóstico , ADN/análisis , Heces/química , Hemoglobinas/análisis , Adenoma/genética , Adenoma/metabolismo , Adenoma/patología , Anciano , Proteína Morfogenética Ósea 3/genética , Pólipos del Colon/genética , Pólipos del Colon/metabolismo , Pólipos del Colon/patología , Colonoscopía , Neoplasias Colorrectales/genética , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Detección Precoz del Cáncer , Femenino , Hemoglobinas/metabolismo , Humanos , Inmunoquímica , Masculino , Persona de Mediana Edad , Proteínas Musculares/genética , Proteínas del Tejido Nervioso/genética , Proteínas Proto-Oncogénicas p21(ras)/genéticaRESUMEN
Previous phylogenetic analyses of the fishes belonging to the genus Oncorhynchus based on mitochondrial DNA data have produced conflicting trees. This is especially true with respect to the relationships among the three most derived Pacific salmon species, the pink salmon (Oncorhynchus gorbuscha), sockeye salmon (Oncorhynchus nerka), and chum salmon (Oncorhynchus keta). Smith (Syst. Biol. 41(1): 41-57, 1992) suggested that introgression in opposite directions on either side of the Pacific ocean may account for some of the conflicting data. The ATPase 6 and ND3 mitochondrial genes were sequenced from Asian and North American representatives of several species of Pacific salmon and the aligned sequences were analyzed along with other data on these genes. Analysis of the ATPase 6 and ND3 sequence data and RFLP data gives strong support for a sister relationship between pink salmon and chum salmon.
Asunto(s)
ADN Mitocondrial/genética , Filogenia , Salmón/genética , Adenosina Trifosfatasas/genética , Animales , Secuencia de Bases , ADN/genética , Cartilla de ADN/genética , Genes , Datos de Secuencia Molecular , Oncorhynchus keta/genética , Oncorhynchus kisutch/genética , Oncorhynchus mykiss/genética , Salmón/clasificación , Homología de Secuencia de Ácido Nucleico , Especificidad de la EspecieRESUMEN
Due to the enormous allelic diversity of the HLA-B locus, it has been difficult to design an unambiguous molecular typing method for the alleles at this locus. Here we describe a technique for the direct sequencing of HLA-B alleles. Initially, HLA-B alleles were PCR-amplified after locus-specific reverse transcription of RNA. Alleles were then separated using denaturing gradient gel electrophoresis (DGGE), which separates DNA fragments based on their sequence composition. Amplification products were excised from the gel and eluted DNA was reamplified and directly sequenced. The derived sequences were aligned to a database of published HLA-B sequences, and an initial allele assignment was made. This approach was theoretically sufficient to type 92 of the 118 known HLA-B alleles. The majority of the remaining 26 alleles contain differences at the beginning of exon 2, a region outside the DGGE-separated PCR products. Therefore, we used heterozygous sequencing of this region to identify 19 of these 26 alleles, raising the resolution power to 111 alleles. Using this technique, we analyzed immortalized cell lines and blood samples from several different sources. Nine immortalized cell lines were obtained from the 10th International Histocompatibility Workshop (IHWS) and nine were derived from aboriginal peoples. Additionally, 25 blood samples were acquired from a panel of donors previously shown to be difficult to type using serological techniques. Altogether, using this new method of allele separation by DGGE followed by direct sequencing, we typed 52 different alleles from 57 individuals, covering 40 serological specificities.